Wilkins Investment Counsel’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.1M Buy
174,115
+70,847
+69% +$4.25M 1.3% 31
2025
Q4
$6.07M Buy
103,268
+7,645
+8% +$465K 0.89% 41
2025
Q3
$5.32M Buy
95,623
+9,010
+10% +$483K 0.75% 40
2025
Q2
$4.46M Buy
86,613
+67,573
+355% +$3.4M 0.63% 45
2025
Q1
$1.12M Sell
19,040
-4,950
-21% -$335K 0.16% 74
2024
Q4
$1.73M Buy
23,990
+6,850
+40% +$503K 0.25% 65
2024
Q3
$1.37M Buy
17,140
+650
+4% +$48.8K 0.19% 68
2024
Q2
$1.18M Buy
16,490
+2,700
+20% +$199K 0.18% 68
2024
Q1
$971K Sell
13,790
-1,050
-7% -$75.1K 0.14% 79
2023
Q4
$1.15M Buy
14,840
+2,390
+19% +$157K 0.28% 51
2023
Q3
$847K Buy
12,450
+3,125
+34% +$247K 0.23% 53
2023
Q2
$761K Buy
9,325
+3,200
+52% +$257K 0.2% 53
2023
Q1
$454K Buy
+6,125
New +$472K 0.12% 62

Other funds holding TECH

Wilkins Investment Counsel's TECH Position: Q1 2026 in Review

Wilkins Investment Counsel increased its Bio-Techne (TECH) stake by 69% in Q1 2026, buying an estimated $4.25M and bringing the position to 174,115 shares worth $9.1M. The position accounts for 1.3% of the portfolio, ranked #31.

Wilkins Investment Counsel first reported a position in TECH in Q1 2023 and has held it in 13 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Wilkins Investment Counsel held 174,115 shares of Bio-Techne worth $9.1M as of Q1 2026.
  • Wilkins Investment Counsel bought 70,847 Bio-Techne shares in Q1 2026, an estimated $4.25M.
  • Bio-Techne made up 1.3% of Wilkins Investment Counsel's portfolio in Q1 2026, its #31 holding.
  • Wilkins Investment Counsel first reported a position in Bio-Techne in Q1 2023 and has held it in 13 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.